Phase I/Ii Study of Oncolytic Herpes Simplex Virus NV1020 in Patients With Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver

Human Gene Therapy - United States
doi 10.1089/hum.2010.020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer

Journal of Clinical Pharmacology
Pharmacology
2009English

Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

A Potent Oncolytic Herpes Simplex Virus for the Therapy of Advanced Prostate Cancer

2004English

Hypoxia Enhances the Replication of Oncolytic Herpes Simplex Virus in P53- Breast Cancer Cells

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer

2005English

S‐1 Plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial

Oncologist
Cancer ResearchMedicineOncology
2019English

Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells

PLoS ONE
Multidisciplinary
2014English

Herpes Simplex Virus I and II: A Therapeutic Approach

South African Family Practice
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy